-
Iran condemned as UN maritime body holds emergency talks on Mideast shipping
-
Iraqi Kurdish shepherds stoic in face of yet another war
-
Iran women's football team return after asylum tussle
-
US launches new era of drug war with Latin American allies
-
How many cargo ships are passing Hormuz strait?
-
'Free France': Macron reveals name of Europe's largest warship
-
Oil surges as Iran gas facilities hit, stocks slide
-
Foreign press group slams Israeli police for breaking journalist's wrist
-
McIlroy happy with back injury recovery as Masters looms
-
Vinicius 'should be loved by everyone' says Donnarumma after celebration row
-
Iran was not rebuilding nuclear enrichment, US intelligence finds
-
Carrick urges England boss Tuchel to call up United trio
-
Three sporting champions to be stripped of titles for non-doping reasons
-
Chilean GDP beats 2025 forecast despite mining dip
-
Storms, warm seas drove sudden drop in Antarctic ice: study
-
Aston Villa want to be more than a 'maybe team' in quest for Europa League
-
Trump administration takes steps to curb energy cost hikes
-
Vaccines facing misinformation spike: WHO experts
-
Pakistan announces Eid 'pause' in conflict with Afghanistan
-
'Happened so fast': UK students panicked by meningitis outbreak
-
WNBA, players union agree 'transformative' labor deal: reports
-
Global music market grows, calls for AI compensation: industry body
-
Maiduguri bombings follow surge of jihadist violence in Nigeria
-
Belgian court suspends TotalEnergies climate trial
-
Troubled waters: Thai fishermen marooned by rising fuel costs
-
Doku adamant Man City still have plenty to play for after Champions League exit
-
Afghanistan vows to avenge deadly Kabul bombing but says open to talks
-
Nigerian president meets royals on 'historic' UK state visit
-
South Lebanon residents flee death and destruction
-
Buttler ready to continue England career despite 'poor' T20 World Cup
-
Why convoys cannot fully protect oil tankers from Iran attacks
-
UK PM leads efforts to halt deadly meningitis spread
-
EU lawmakers back ban on sexualised AI deepfakes
-
Stripping Senegal of AFCON title a 'disgrace for Africa' say fans
-
Under Hezbollah fire, people in north Israel hope for better days
-
Iran women's football team cross Turkish border to head home: AFP
-
Fear in central Beirut as Israel strikes, with and without warning
-
'France is wild': Macron to unveil name of Europe's largest warship
-
Arsenal's Trossard says Leverkusen win ideal ahead of League Cup final
-
Israel conducts wave of strikes on Beirut
-
Seven-year term sought for Norway princess's son for alleged rapes
-
US govt says Anthropic AI an 'unacceptable risk' to military
-
Head of victorious Nepal party hails 'win for the country'
-
UN maritime body kicks off emergency talks on Mideast shipping
-
Israel says killed Iran intel chief, tells military to hunt down officials
-
China tech giant Tencent bets on AI agents
-
AFCON stripping of Senegal's title a 'disgrace for Africa' say fans
-
Japan thrash South Korea 4-1 to set up Women's Asian Cup final with Australia
-
Fernandez uncertain over Chelsea future after Champions League exit
-
Iran women's football team arrive in eastern Turkey, heading home
Tenon Medical, Inc. Sets Date for Fourth Quarter and Full Year 2025 Earnings, Reaffirms Expected Revenues
Fourth Quarter 2025 Revenue of $1.45 to $1.48 Million, representing growth of ~90% year over year
Full Year 2025 Revenue of $3.91 to $3.94 Million, representing growth of ~20% year over year
LOS GATOS, CA / ACCESS Newswire / February 5, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients suffering from sacro-pelvic disorders, today announced plans to release financial results for the fourth quarter and full year 2025 ended December 31, 2025 after market close on Thursday, March 19, 2026. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.
Date: | Thursday, March 19, 2026 |
Time: | 4:30 p.m. Eastern time |
Dial-in: | 1-877-407-0792 |
International Dial-in: | 1-201-689-8263 |
Webcast: |
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
An audio playback of the call will be available through April 2, 2026, on Tenon's Investor Relations website at http://ir.tenonmed.com/ or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671 (International). The access code will be 13758268.
About Tenon Medical, Inc.

Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022, Tenon is focused on three commercial opportunities with its System in the SI Joint market which include: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants and 3) Augmenting spinal fusion. For more information, please visit www.tenonmed.com.
The Tenon Medical logo shown above, and Catamaran®, PiSIF®, CAT PiSIF®, ETAD®, Posterior Inferior Sacroiliac Fusion®, CAT SIJ Fusion System®, Catamaran SIJ Fusion System®, Catamaran Inferior Posterior Fusion System®, Catamaran Transfixation Fusion System®, Catamaran Transfixation Fusion Device®, SImmetry® are registered trademarks of Tenon Medical, Inc. MAINSAILTM, and SImmetry+ are also trademarks of Tenon Medical, Inc.
Investor Contact
Shannon Devine
MZ North America
203-741-8811
[email protected]
SOURCE: Tenon Medical, Inc.
View the original press release on ACCESS Newswire
L.Davis--AMWN